Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (191-200 of 326) with videos related to

Pageof 33
Sort By:
International Journal of Molecular Sciences|January 21, 2023
The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver DiseaseAngelo Armandi, Giorgia Colombo, Chiara Rosso, et al.
JHEP Reports : Innovation in Hepatology|April 18, 2022
Metabolic signatures across the full spectrum of non-alcoholic fatty liver diseaseAidan J McGlinchey, Olivier Govaere, Dawei Geng, et al.
Obesity (Silver Spring, Md.)|August 8, 2021
Preparing for the NASH epidemic: A call to actionFasiha Kanwal, Jay H Shubrook, Zobair Younossi, et al.
Cell Reports. Medicine|November 20, 2024
Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitisSilvia Sabatini, Partho Sen, Fabrizia Carli, et al.
Journal of Clinical Medicine|February 15, 2022
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver DiseaseAngelo Armandi, Chiara Rosso, Aurora Nicolosi, et al.
Hepatology (Baltimore, Md.)|April 8, 2010
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver diseaseLuca Valenti, Ahmad Al-Serri, Ann K Daly, et al.
Journal of Hepatology|July 14, 2019
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver diseaseChiara Rosso, Konstantin Kazankov, Ramy Younes, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 16, 2021
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell ProliferationBeatrice Foglia, Salvatore Sutti, Stefania Cannito, et al.
Journal of Clinical Medicine|March 19, 2020
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel DiseasesGian Paolo Caviglia, Chiara Rosso, Francesco Stalla, et al.
Journal of Clinical Medicine|January 21, 2023
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseAngelo Armandi, Chiara Rosso, Ramy Younes, et al.
Pageof 33

Showing results (191-200 of 326) with videos related to

Sort By:
Pageof 33
International Journal of Molecular Sciences|January 21, 2023
The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver DiseaseAngelo Armandi, Giorgia Colombo, Chiara Rosso, et al.
JHEP Reports : Innovation in Hepatology|April 18, 2022
Metabolic signatures across the full spectrum of non-alcoholic fatty liver diseaseAidan J McGlinchey, Olivier Govaere, Dawei Geng, et al.
Obesity (Silver Spring, Md.)|August 8, 2021
Preparing for the NASH epidemic: A call to actionFasiha Kanwal, Jay H Shubrook, Zobair Younossi, et al.
Cell Reports. Medicine|November 20, 2024
Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitisSilvia Sabatini, Partho Sen, Fabrizia Carli, et al.
Journal of Clinical Medicine|February 15, 2022
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver DiseaseAngelo Armandi, Chiara Rosso, Aurora Nicolosi, et al.
Hepatology (Baltimore, Md.)|April 8, 2010
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver diseaseLuca Valenti, Ahmad Al-Serri, Ann K Daly, et al.
Journal of Hepatology|July 14, 2019
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver diseaseChiara Rosso, Konstantin Kazankov, Ramy Younes, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 16, 2021
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell ProliferationBeatrice Foglia, Salvatore Sutti, Stefania Cannito, et al.
Journal of Clinical Medicine|March 19, 2020
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel DiseasesGian Paolo Caviglia, Chiara Rosso, Francesco Stalla, et al.
Journal of Clinical Medicine|January 21, 2023
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseAngelo Armandi, Chiara Rosso, Ramy Younes, et al.
Pageof 33